Vitamin D - a remark on the known and a survey of the lesser-known facts by Kubesova, H. M. et al.
НАУЧНЫЕ ВЕДОМОСТИ Р Я  Серия Медицина. Фармация. 2011. № 22 (117). 105
Выпуск 16/1
УДК 577.161.6
VITAMIN D -  A REMARK ON THE KNOWN AND A SURVEY OF THE LESSER-KNOWN FACTS
H.M. Kubesova 
J. Tumova 
V. Polcarova 
H. Meluzinova
Departm ent o f  Internal 
Medicine, Geriatrics, 
and Practical Medicine,
M asaryk University Faculty o f  
M edicine and Faculty Hospital,
Brno, Czech Republic
e-mail: hkubes@med.muni.cz
Introduction.Vitamin D belongs to the group of liposoluble vitamins and is natu­
rally present in a relatively narrow spectrum of commonly used diet components. The most 
important source of vitamin D is the ultraviolet component of solar radiation, which triggers 
the synthesis of vitamin D in our skin. Vitamin D obtained from the diet or synthesised in the 
skin is biologically inert cholecalciferol, and it has to undergo two further processes of hy- 
droxylation to become active 25-hydroxycholecalciferol -  calcidiol, or 1,25- 
dihydroxycholecalciferol -  calcitriol. The former process occurs in the liver, the latter in the 
kidneys [1].
The main function of vitamin D is support of calcium resorption from the intestine 
and maintenance of adequate serum levels of calcium and phosphorus as an important pre­
condition for bone growth and normal mineralisation of bone mass. More recently, it was 
found that vitamin D takes part in the regulation of the activity of osteoblasts and osteoclasts 
in the process of bone remodelling. Seen from this aspect, deficiency of vitamin D causes 
rickets in children and osteomalacia in adults; along with lack of calcium the development of 
osteoporosis and a significant increase of the number of osteoporotic fractures are markedly 
accelerated [2].
The deepening knowledge of the cellular and subcellular structure and functioning of 
the human organism lets ensue numerous as yet unforeseen facts. Vitamin D demonstrably 
becomes involved in immunity processes, in the functioning of the neuron, in insulin reactiv­
ity in DNA self-repair, in processes of proliferation, differentiation, and apoptosis. The pres­
ence of vitamin D receptors has been proved in many types of tissue cultures, in some of the 
types even including the ability to convert to active forms of vitamin D [3].
Vitamin D and contemporary population.In the last several years, reports have 
been appearing on the very low level of vitamin D in the majority of population of the middle 
geographical area, irrespective of the continent [4,5]. As the most suitable for monitoring vi­
tamin D metabolism has been considered 25OHvit D3, which reflects the amount of the vi­
tamin obtained in the diet and synthesised in the skin and has the corresponding biological 
half-life of 15 days; it informs us on the tissue deposits of vitamin D. Calcitriol -  i ,25(OH)2 vit 
D -  is not a suitable clinical indicator because its level drops only at the moment when the 
deficit in the organism is already very marked [1]. For the evaluation of the current serum 
level of vitamin D there exists a standard used in Germany, where the healthy population 
should reach a serum level between 50 and 200 nmol/l. The US National Institute of Health 
recommends the lower limit of the standard to equal 37.5 nmol/l, when a level lower than 
this is already considered as a state when there appear severe disorders of bone metabolism 
and of the other processes in which vitamin D gets involved. Values over 500 nmol/l are con­
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sidered to be toxic [3]. According to the first results of testing, the Czech population finds it­
self situated with its average value just on the borderland between 30 and 40 nmol/l, which 
means that at least half the population does not meet the level necessary for high-quality re­
modelling of the bone [5].
The current recommendation concerning the daily uptake of vitamin D differs mark­
edly from the so far customary practice, when maximum attention was given to the uptake of 
vitamin D in children. At present it has been known and confirmed by numerous studies that 
supplementation with vitamin D and calcium in older patients in a dose double that recom­
mended for childhood age has a significant positive effect on reduction of the number of falls 
and fractures in postmenopausal women as well as in the senium, and with deficient serum 
levels a rise by 1 nmol/l for each 100 IU may be expected [6]; see Table 1.
Table 1
Recommended daily maintenance doses of vitamin D by gender and age
A ge Children Men Women Pregnancy Lactation
0 to 13 200 IU
14 to 18 200 IU 200 IU 200 IU 200 IU
19 to 50 200 IU 200 IU 200 IU 200 IU
51 to 70 400 IU 400 IU
over 70 600 IU 600 IU
Sources of vitamin D.The diet in the composition usual in the Czech cuisine is an 
insufficient source of vitamin D, with only a half of the recommended daily dose of 400 IU 
maximum, i.e. 200 IU being reached. Of the fish products available on our market, signifi­
cant quantities of vitamin D are contained in salmon, mackerel, and cod liver [7]; see Table 2.
Table 2
The content of vitamin D in 100 g of selected foodstuffs
FR UIT IU №
Fresh avocado 200 5
M USHROOMS
Boletus, dried 1120 28
Boletus 124 3.10
Common morel 124 3.10
Chanterelle 84 2.10
Slippery jack 80 2.00
Brown birch boletus 80 2.00
Milk cap 80 2.00
Honey fungus 80 2.00
Field mushroom, grown 78 1.94
Chanterelle (preserved) 48 1.20
Field mushrooms (preserved) 46 1.14
CAKES AN D  PASTR Y
W alnut pie 44 1.09
Sponge biscuits -  spoonful 41 1.02
CREAM  AN D  M ILK
W hole milk, powdered 50 1.24
W hipped cream 44 1.10
CHEESE
Processed cheese, 45% fat in 
dry matter (FDM)
125 3.13
Gouda, 45% FDM 50 1.25
FISH IU №
Eel, smoked 3600 90.00
Kipper 1200 30.00
Young herring 1080 27.00
Herring 1068 26.70
Common eel 800 20.00
Anchovy in brine 696 17.39
Herring -  fillet in tomato sauce 660 16.50
Salmon 652 16.30
Herring, marinated 520 13.00
Salmon (preserved) 460 11.50
Sardine 430 10.75
Herring, baked 406 10.16
Rollmop 370 9.25
Oyster 320 8.00
Halibut, smoked 172 7.30
Caviar, genuine 235 5.87
Sardines in oil 228 5.71
Caviar, imitation 204 5.10
Halibut 200 5.00
НАУЧНЫЕ ВЕДОМОСТИ Р Я  Серия Медицина. Фармация. 2011. № 22 (117). 107
Выпуск 16/1
Sole 180 4.50
Common trout 180 4.50
Tuna in vegetable oil 164 4.11
Mackerel 160 4.00
W hitefish 153 3.83
Perch 144 3.60
Golden perch, smoked 136 3.39
Spined loach 125 3.12
Plaice 108 2.70
Carp 108 2.70
Pike 108 2.70
Red perch 92 2.30
Common cuttlefish, fresh, ther­
mally treated
91 2.28
Turbot 72 1.80
Tench 72 1.80
Mackerel, smoked 52 1.31
Atlantic cod (young) 52 1.30
Plaice, smoked 50 1.27
Emmental, 45% FDM 44 1.10
Gorgonzola 40 1.00
Blue cheese, 50% FDM 40 1.00
OILS A N D  FATS
Fish oil 12000 300.00
Margarine, low-calorie 100 2.50
Margarine 100 2.50
Margarine, reduced-fat 100 2.50
Butter 50 1.24
Butter, tried 48 1.20
EGGS
Chicken egg (yolk) 223 5.58
Goose egg 200 5.00
Duck egg 200 5.00
Chicken egg (whole) 117 2.93
OFFAL
Mutton and lamb liver 80 2.00
Beef liver 68 1.70
Chicken liver 52 1.30
Pork liver 45 1.13
The content of vitamin D in selected kinds of food.Solar radiation of UVB type 
permeates the human skin and activates 7-dehydrocholesterol found in the skin to D3. The 
geographical latitude, season of the year, time of the day, quantity of smog, cloudiness, con­
tent of melanin in the skin and, last but not least, use of screening filters all affect exposure to 
solar radiation and the subsequent synthesis of vitamin D. Generally it is reported that lati­
tudes north of 42° N Lat mean insufficient intensity of radiation for vitamin D synthesis in 
the period from November to February; in the more northerly areas the interval of insuffi­
cient exposure makes up to 6 months in the year. Cloudy sky reduces the intensity of radia­
tion by 50 %. Use of sunscreens with a protection factor of over 8 effectively blocks vitamin 
D-producing rays [1].
What is important, however, is the dilemma between exposure to solar radiation with 
the aim to ensure delivery of vitamin D and the risk of carcinogenicity of UV radiation. To 
ensure adequate level vitamin D, it is recommended to expose the face, upper and lower ex­
tremities, or the back to sunrays for a period of 5 to 30 minutes in the interval between 10
a.m. and 3 p.m. Unfortunately, reliable data evaluating the cumulative lifelong exposure to 
solar radiation in the context of the rising risk for the development of skin malignancies are 
not known as yet.
In the last years, there have been arriving repeatedly alarming results of population 
studies reporting on tens of per cent of population with vitamin D deficiency. This concerns 
especially countries of the temperate zone, both on the American and European continents 
[4]. Particularly endangered groups are formed by seniors with reduced capability of skin 
synthesis and renal hydroxylation of vitamin D, furthermore people with restricted exposure 
to solar radiation, people with dark complexion, people with an intolerance to dairy products, 
patients observing in the long term fat-free diet, patients with malabsorption, extreme obe­
sity, or those after bypass surgery of the stomach [3].
Potential consequences of long-term deficiency of vitamin D
Vitamin D and cognitive functions.Discussions on neuroprotective action of vi­
tamin D have been going on for many years. One of the studies, which attempted to check the 
relationship between the level of vitamin D and cognitive performance, showed a significant 
positive dependence between the MMSE score achieved and vitamin D level [8]. A  significant 
difference in the serum levels of vitamin D was observed in a study that compared patients
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with Parkinson’s disease, Alzheimer’s dementia, and a control sample. In the group with 
Parkinson’s disease, there were significantly more patients with low level of vitamin D, and 
the average level in this group was also significantly lower than in the control group. The pa­
rameters monitored in patients with Alzheimer’s dementia were placed approximately in the 
middle [9].
Another argument for the existence of a mutual relationship between vitamin D and 
cognitive affection was provided by the study concerned with polymorphism of the neuronal 
receptor for vitamin D; the configuration of the receptor reducing the affinity to vitamin D as 
of a protective factor maintaining the neuronal homeostasis of calcium was significantly more 
frequent in patients with Alzheimer’s dementia [10].
The mechanism of action of vitamin D has been partly explained by its favourable influ­
ence on intestinal resorption and by an increase of the serum level of calcium, which leads to a 
dampening of parathormone secretion and the subsequent lowering of the level of free intracel­
lular calcium as a neurotoxic factor that slows down the neuron’s conductivity, damages the 
cellular membrane of the neuron, and accelerates the neuron’s destruction. There has also been 
described an increased level of free intracellular calcium in neurons which exhibited the pres­
ence of neurofibrillary structures and tau protein in Alzheimer’s dementia [11].
Vitamin D and depression.As early as since the 1990s references have kept ap­
pearing to the favourable influence of vitamin D on seasonal mood disorders, although at the 
beginning it was not clear if this was an additional effect to the influence of daylight [12].
The effect of the actual vitamin D on mood improvement was confirmed on healthy 
probands in the winter period by administration of 400 IU, 800 IU of vitamin D3, and pla­
cebo in the form of a randomised double-blind study; questionnaires confirmed an improve­
ment of the mood in probands to which active substance was administered [13].
A similarly designed study confirmed the effect of administration of vitamin D in older 
men living in their own environment, but only doses exceeding 1,000 IU were efficient [14].
The mechanism of action of vitamin D is interpreted by stimulation of tyrosine hy­
droxylase as an enzyme enhancing the formation of serotonin [15].
Vitamin D and tumours.Vitamin D shows the ability to inhibit mitogen-activated 
protein kinase (MAPK) and thus negative growth regulation of mammary carcinoma cells 
both in vivo and in vitro. The mechanism of action is interpreted in two ways: it regulates 
gene transcription of the gene through the specific intracellular vitamin D receptor (VDR) 
and, by means of activation of transmembrane transfer, it induces a fast non-transcriptional 
response of the character of modification of growth factors and peptide hormones [16]. Bas­
ing on these activities there occurs an antiproliferative, proapoptotic influence on many cell 
lines [17].
In a study realised at the Mayo Clinic in the latter half of 2009, women with invasive 
mammary carcinoma had a significantly lower level of vitamin D, and a significant negative 
relationship between the oncological type of tumour and vitamin D level [18].
In discussions on the mutual relationship between vitamin D and tumorous growth 
there frequently appears the theme of exposure to solar radiation as a significant source of 
vitamin D for man in contrast to the rising occurrence of malignant melanoma, in whose 
pathogenesis exposure to solar radiation plays indeed an important role. A Swedish study 
was concerned with the question whether exposure to UV radiation was able to reduce the 
total tumour morbidity and mortality rates. Exposure to UV radiation through sunrays ful­
filled this assumption, whereas exposure to UV radiation in solariums had an opposite effect, 
even though both groups of probands showed increased serum levels of vitamin D [19].
In discussions regarding the mutual relationship between the vitamin D level and po­
tential antiproliferative action and solar radiation as the principal presumed pathogenetic 
factor of the development of malignant melanoma, but also as a source of vitamin D, there 
arises the question of quantity, i.e., what the optimal serum level of vitamin D should be. The 
authors from the University of Leeds denote values between 70 and 100 nmol/l as optimal, 
both for patients with malignant melanoma and for the healthy population [17].
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Another area of oncology, in which the potential contribution of vitamin D is dis­
cussed, is colorectal malignancies. In patients with colonic adenomas, a negative correlation 
of the frequency of adenomas and the serum level of vitamin D was detected. No such similar 
association has been corroborated for hyperplastic polyps [20]. On the other hand, in pa­
tients with already developed colorectal carcinoma, a highly significant negative dependence 
has been demonstrated on the serum level of vitamin D; in the case of rectal localisation the 
dependence was even closer [21].
Vitamin D and immunity.The assumption of a modification of the immune system 
by vitamin D is based on the detection of production of vitamin D by activated macrophages 
and on the proved existence of vitamin D receptors on cells of the immune system. In this 
way vitamin D modifies the local progress of the inflammation in the form of negative feed­
back. Also, a significant association has been proved between the low level of vitamin D and 
susceptibility to chronic mycobacterial or viral infections. On the contrary, an adequate level 
of vitamin D encourages the CD4-mediated cellular and antibody immunity of the surface of 
skin and mucous membrane -  for example, the activity of 1a-hydroxylase has been demon­
strated, which is an enzyme generating active vitamin D in the mucous membrane of the res­
piratory tract, alveolar macrophages, and dendritic cells. Another important area of function­
ing of vitamin D in human immunity is ensuring and maintaining the tolerance of the actual 
tissues -  it has been demonstrated on model diseases of the type of multiple cerebrospinal 
sclerosis, insulin-dependent diabetes mellitus, and non-specific intestinal inflammations that 
vitamin D can strengthen the function of T suppressors and thus improve immunological tol­
erance of the actual tissue antigens [22,23,24,25].
Vitamin D and the muscle.The favourable influence of vitamin D on the mainte­
nance and new formation of muscular mass and preservation of muscle strength has been 
demonstrated. The mechanism of action is interpreted by stimulation of the phosphorylation 
of tyrosine contained in the myoblasts via phospholipase C, which participates in the mobili­
sation of the intracellular supplies of calcium, and further by protein kinase stimulation [26].
Loss of muscular mass is one of the principal factors influencing the self-sufficiency of 
seniors; loss of type II muscle fibres means a marked increase of the risk of falls and, in com­
bination with the present osteoporosis, also an increased risk of fractures. According to the 
results of an Australian study carried out on seniors living in their own environment, indi­
viduals with low serum levels of vitamin D exhibited lower muscular mass, lower muscle 
strength, and generally lower levels of physical activity [27]. The development of sarcopenia 
is in an essential way modified by the present concurrent diseases and often overlaps with 
cachexia. Apart from substitution of the low level of vitamin D, references from the practice 
suggest the possibility of using physical targeted load for the maintenance or recovery of 
muscle strength and nimbleness especially in those institutions for seniors where patients 
with Alzheimer’s dementia were also successfully involved in the programme [28].
An intervention study of Belgian authors demonstrated an increase in muscle 
strength, multiplication of muscle mass, and increase of bone density after a 6-month ad­
ministration of vitamin D at a dose of 880 IU per day. However, neither the administration of 
double doses of vitamin D nor whole-body vibration training provided any further improve­
ment [29].
With regard to the seriousness of sarcopenia and possible consequences in terms of 
increased risk of falls, loss of self-sufficiency, and a significant worsening of life quality, rec­
ommendations for the management of sarcopenia have even appeared in the official materi­
als of the American Society of Health Institution Directors. Recommendations include train­
ing with combined strength and endurance loads, adequate intake of proteins, and supple­
mentation of vitamin D in case of its decreased serum levels [30].
Vitamin D and the bone.The significant positive dependence of bone density and 
negative dependence of the level of parathormone, frequency of fractures and frequency of 
falls on the serum level of vitamin D has been demonstrated by many studies. In a number of 
studies however, the effect of the actual vitamin D and of calcium could not be exactly differ-
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entiated from each other. With regard to the senior population, its self-sufficiency, and ability 
to remain in its own environment, the drop in the frequency of falls and osteoporotic frac­
tures in case of long-time administration of vitamin D in a dose exceeding 700 IU per day 
and of calcium in a dose exceeding 1,000 mg per day is, however, essential. The above­
mentioned favourable influence of vitamin D on the preservation of muscle mass is sure to 
also take part in the decline of the frequency of falls [6].
In view of the potential undesirable cardiovascular effects of calcium supplementation 
with a relatively low influence on further reduction of the frequency of fractures compared to 
the administration of vitamin D alone, there have been lately appearing recommendations for 
prioritisation of increased supply of calcium through usual diet and not by pharmaceutical 
preparations [31].
Vitamin D and diabetes mellitus. During the last years, ever more information 
has kept appearing on the mutual influence of vitamin D and diabetes mellitus of both types 1 
and 2. The mechanism is interpreted by the negative influence of low levels of vitamin D on 
both inborn and acquired immunity and the ensuing worsened tolerance of actual antigens 
[22,32,33] with the subsequent inflammatory autoimmune reaction. This assumption is also 
corroborated by the demonstration of increased proinflammatory activity in patients with 
type 1 diabetes and low levels of vitamin D. These patients had significantly lower levels of 
vitamin D compared to the control group of healthy individuals and exhibited a significant 
negative correlation between the serum level of vitamin D and the CRP value [34].
It is true that the multicentric study IMDIAB XIII did not confirm, in a randomised 
double-blind study, the favourable influence of vitamin D supplementation on the function of 
pancreatic beta cells or on the levels of glycosylated haemoglobin in recent type-1 diabetics, 
but the dose applied was only 0.25 ^g/day against the commonly recommended dose of 10
^g/day [35].
On the other hand, the study in which type-1 diabetics with serum levels of vitamin D 
lower than 50 nmol/l were using 4,000 IU of vitamin D per day demonstrated a significant 
reduction of the value of glycosylated haemoglobin and a drop in insulin consumption [36].
So far, the facts ascertained come from experiments on animals, and/or from observa­
tion studies; generally, authors of communications concerned with the relationship of vita­
min D and type-1 diabetes mellitus or other extraskeletal diseases of autoimmune character 
appeal for further studies that would check the hitherto ascertained facts [37].
In relation to type-2 diabetes, vitamin D deficiency has been shown to lead to in­
creased insulin resistance, increased glycaemia, and to a rise in blood pressure. Supplemen­
tation with vitamin D leads to an increase in the sensitivity of tissues to insulin, to a drop in 
glycaemia, and to a drop in blood pressure values. The results of some in vivo studies lack 
uniformity, most frequently due to methodology; nevertheless, type-2 diabetics are advised to 
maintain the level of vitamin D around 85 nmol/l all year long [38].
Another unfavourable effect of vitamin D deficiency in type-2 diabetics is endothelial 
dysfunction with demonstrated insufficient ability of vasodilation, and a drop in the number 
of circulating endothelial progenitor cells with subsequently increased risk for vascular dia­
betic complications [39].
Discussion — conclusion. From the review presented above it follows that, along 
with the introduction of routine examination of the serum level of vitamin D, a variety of is­
sues has been opened of not only technical but also medical character. On the one hand 
doubts may arise concerning the methodology of examination and rate of relevance of the 
levels detected for a given sector of population; however, reports on low serum levels coming 
from numerous countries are similar. Seen from the medical point of view, the often striking 
discrepancy between the very low serum level of vitamin D and the absolutely intact clinical 
state of a given patient is sure to cause confusion. However, the problem here is the long-time 
character of the low-level effect on the given structures and, of course, also the reversibility or 
irreversibility of already occurred changes.
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In this field a great deal of new information is likely to be expected in the near future. 
With regard to the potential consequences for the present-day middle- and early senior-age 
population it is highly desirable to introduce positive findings very quickly into practical 
medicine in the interest of encouragement of the state of health with subsequent prolonga­
tion of self-sufficiency of this part of population. If we project for ourselves the image of a 
senior with advanced geriatric syndromes, that is, one with cognitive disorders, depressive, 
with instability and falls, with loss of muscle mass and in danger of falls and osteoporotic 
fractures, susceptible to infections, then the attention given to supply of vitamin D from the 
middle age might well assist to somewhat mitigate this unfavourable picture.
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ВИТАМИН Д -  К ВОПРОСУ ОБ ИЗВЕСТНЫХ И МАЛОИЗВЕСТНЫХ ФАКТАХ
Х. КУБЕШОВА 
Й. ТУМОВА 
В. ПОЛЬЦАРОВА 
Х. МЕЛУЗИНОВА
Кафедра внутренней 
медицины, гериатрии и 
общей врачебной практики 
медицинского факультета 
им. Масарыка и
факультетской клиники, Брно, 
Чешская Республика
Витамин Д -  один из жирорастоворимых витаминов -  
имеет широкое клиническое применение в детской практике, в 
т.ч. для остеогенеза. Однако, в последние годы было получено 
много интересных информативных данных, отражающих новые 
сведения об участии витамина Д во многих функциях 
человеческого организма. В настоящей статье обсуждаются 
вопросы влияния витамина Д на иммунную систему, 
кардиогенез, остеогенез,, управление депрессией, а также другие 
влияния в организме людей старших возрастных групп.
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